Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another buyout in the small pharma space

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jun 12, 2023 11:10am

142 Views

Post# 35491530

RE:RE:Another buyout in the small pharma space

Interesting as this is for a rare form of kidney disease, so not an important pool of patients.

Also:

Novartis has stepped in before Chinook has a chance to validate that idea in a phase 3 trial, which is due to read out in the fourth quarter.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”